Tci Gene (ROCO:6879) Price-to-Operating-Cash-Flow : 115.33 (As of May. 22, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Price-to-Operating-Cash-Flow?

As of today (2024-05-22), Tci Gene's share price is NT$77.50. Tci Gene's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.67. Hence, Tci Gene's Price-to-Operating-Cash-Flow Ratio for today is 115.33.

The historical rank and industry rank for Tci Gene's Price-to-Operating-Cash-Flow or its related term are showing as below:

ROCO:6879' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 17.85 Med: 23.33 Max: 131.6
Current: 115.33

During the past 5 years, Tci Gene's highest Price-to-Operating-Cash-Flow Ratio was 131.60. The lowest was 17.85. And the median was 23.33.

ROCO:6879's Price-to-Operating-Cash-Flow is ranked worse than
90.69% of 290 companies
in the Biotechnology industry
Industry Median: 26.84 vs ROCO:6879: 115.33

Tci Gene's Cash Flow from Operations per share for the six months ended in Dec. 2023 was NT$-1.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.67.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Tci Gene was -85.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -38.70% per year.

During the past 5 years, Tci Gene's highest 3-Year average Operating Cash Flow per Share Growth Rate was -3.80% per year. The lowest was -38.70% per year. And the median was -21.25% per year.

Tci Gene Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Tci Gene's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Price-to-Operating-Cash-Flow Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

26.18

123.89

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial				-	-	26.18	-	123.89

Competitive Comparison of Tci Gene's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Tci Gene's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Tci Gene's Price-to-Operating-Cash-Flow falls into.

Tci Gene Price-to-Operating-Cash-Flow Calculation

Tci Gene's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	77.50	/	0.672
	=	115.33

Tci Gene's Share Price of today is NT$77.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tci Gene's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$0.67.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Tci Gene Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Tci Gene's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines